Contrast-enhanced Magnetic Resonance Angiography Investigation of Intracranial Aneurysms and Prospective Study of Risk Factors
NCT ID: NCT00997698
Last Updated: 2009-10-27
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
4000 participants
OBSERVATIONAL
2009-01-31
2011-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Screening Intracranial Aneurysms With Magnetic Resonance Angiography (MRA) in China
NCT00926172
The Natural Course of Unruptured Intracranial Aneurysms in a Chinese Cohort
NCT03117803
Risk Assessment and Mechanism Analysis of Intracranial Multiple Aneurysm Instability Based on High-resolution Magnetic Resonance, Imaging Histology and Hemodynamics
NCT06539767
Investigation of Hemodynamics and Radiomics Based on High Resolution Magnetic Resonance Imaging for Predicting the Outcomes of Intracranial Dissecting Aneurysm
NCT07335029
Contrast-free Magnetic Resonance Angiography (MRA) at 3.0 T for Intracranial Aneurysm Detection
NCT01031147
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
In retrospective analysis, conventional risk factors for intracranial aneurysms include hypertension, hyperlipidemia, diabetes mellitus (DM), smoking history, and family history, etc. However, retrospective analysis probably gives an underestimation or overestimation of the actual results. Prospective analysis will get accurate data on the risk factors relating to intracranial aneurysms
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Willing to undergo study procedures
* Who are fully informed about the study and have signed the informed consent form
Exclusion Criteria
* History of intracranial tumor
* History of cerebral infarction
* Acute stroke
* Require emergency treatment
* Contraindication for MRI examination
* Severely impaired renal functions
* Known anaphylactic reaction to MR contrast media
* Pregnancy or nursing
20 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Second Military Medical University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Changhai Hospital affiliated to Second Military Medical University
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Ping J Lu, MD, PhD
Role: STUDY_DIRECTOR
Changhai Hospital affiliated to Second Military Medical University
Qi Liu, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Changhai Hospital affiliated to Second Military Medical University
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Changhai Hospital, Second Military Medical University
Shanghai, Shanghai Municipality, China
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
SecondMMU
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.